A Study of Melphalan With or Without Siltuximab in People With Multiple Myeloma Having an Autologous Stem Cell Transplant

NCT06679829 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

215

Enrollment

OTHER

Sponsor class

Conditions

Multiple Myeloma

Interventions

DRUG: Siltuximab
DRUG: Melphalan

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]